FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2402086470> ?p ?o ?g. }

• W2402086470 endingPage "9" @default.
• W2402086470 startingPage "25" @default.
• W2402086470 abstract "For the most patients with pulmonary tuberculosis, treatment are successful and the chemotherapy can be finished within a year. Few patients, though receiving standard anti-tuberculous chemotherapy, expectorate tubercle bacilli continuously for more than a year. They are named chronic excretors of mycobacterium tuberculosis bacilli or intractable tuberculosis patients. Being suspected that this phenomenon is produced by many factors, it is necessary to correspond suitably to these patients for eradication of tuberculosis. This symposium was organized to search for some factors on the bacterium and on the host, which caused patients to be the chronic excretors or intractable patients. We hope that our discussion may contribute to take the appropriate measures for such hard diseases. The main results are summarized as follows. 1) Dr. TSUCHIYA conducted a epidemiologic study by questionaire method to 33 Japanese national sanatoriums. The total number of tuberculosis patients admitted to these hospitals on a optimal day from September to October 1994 were 1,295. Numbers of patients who had expectorated bacilli continuously for more than 12 months were 85 (6.6%). The male/female ratio was about 3, their average age was 64. They had a tendency of thin-physique and most of them had past histories of tuberculosis, being the refractory cases. The average clinico-epidemiologic conditions of the patients came before our eyes. 2) Dr. OGATA analysed the results of drug sensitivity tests of mycobacterium tuberculosis bacilli from 2,630 pulmonary tuberculosis patients which contained 179 chronic excretors. The only 2.2% of bacilli from the chronic excretors were sensitive to RFP (50 gamma). The 99.4% of bacilli showed to be resistant to INH (0.1 gamma). The 39.1% of bacilli were sensitive to streptomycin (20 gamma). To EB (2.5 gamma) 34.1% of bacilli were sensitive. However, the ratio of chronic excretors in tuberculosis patients was not increased in these 17 years, and for many cases of these chronic excretors, they are all inexperienced in PZA, multi-sensitive-drug chemotherapy including PZA and OFLX were useful. Some of them underwent lobectomy combined for effective chemotherapy. The chronic excretors are likely to be affected multidrug-resistant bacilli, and it is important for such cases to treat intensively with several kinds of sensitive drugs. 3) Dr. FUJIWARA studied Interleukin-10 (IL-10) producing function of monocytes stimulated by Mycobacterium tuberculosis (M-TB). The IL-10 usually down-regulates a number of different macrophage functions, including microbicidal activity against intracellular bacteria such as Mycobacterium species. They found that the mean IL-10 production by peripheral blood mononuclear cells (PBMC) obtained from a healthy tuberculin-reactor stimulated with multidrug-resistant M-TB was greater than that with drug-sensitive M-TB. The IL-10 producing cells were monocytes, not T-lymphocytes. They moreover found that PBMC from intractable tuberculosis patients secreted greater amounts of IL-10 than those of healthy subjects. These data may give a hint for development of new immunotherapeutic methods for multi-drug-resistant tuberculosis patients. 4) Dr. HARA analysed clinical courses of 580 consecutive cases of bacilli positive pulmonary tuberculosis admitted in his hospital from a point of underlying diseases. All of dead 24 cases had some underlying diseases; diabetes mellitus 3, chronic liver diseases 4, others 17 (malignant neoplasms, central nerve vascular diseases, malnutritional condition, etc). (ABSTRACT TRUNCATED)" @default.
• W2402086470 created "2016-06-24" @default.
• W2402086470 creator A5003525950 @default.
• W2402086470 creator A5004298402 @default.
• W2402086470 creator A5021060288 @default.
• W2402086470 creator A5035256309 @default.
• W2402086470 creator A5049961806 @default.
• W2402086470 creator A5065699858 @default.
• W2402086470 creator A5087721082 @default.
• W2402086470 creator A5091001665 @default.
• W2402086470 date "1996-01-01" @default.
• W2402086470 modified "2023-09-27" @default.
• W2402086470 title "[II. multidisciplinary analysis of chronic excretors of Mycobacterium tuberculosis bacilli]." @default.
• W2402086470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8808265" @default.
• W2402086470 hasPublicationYear "1996" @default.
• W2402086470 type Work @default.
• W2402086470 sameAs 2402086470 @default.
• W2402086470 citedByCount "0" @default.
• W2402086470 crossrefType "other" @default.
• W2402086470 hasAuthorship W2402086470A5003525950 @default.
• W2402086470 hasAuthorship W2402086470A5004298402 @default.
• W2402086470 hasAuthorship W2402086470A5021060288 @default.
• W2402086470 hasAuthorship W2402086470A5035256309 @default.
• W2402086470 hasAuthorship W2402086470A5049961806 @default.
• W2402086470 hasAuthorship W2402086470A5065699858 @default.
• W2402086470 hasAuthorship W2402086470A5087721082 @default.
• W2402086470 hasAuthorship W2402086470A5091001665 @default.
• W2402086470 hasConcept C126322002 @default.
• W2402086470 hasConcept C141071460 @default.
• W2402086470 hasConcept C142724271 @default.
• W2402086470 hasConcept C2776870249 @default.
• W2402086470 hasConcept C2776967927 @default.
• W2402086470 hasConcept C2777975735 @default.
• W2402086470 hasConcept C2781069245 @default.
• W2402086470 hasConcept C523546767 @default.
• W2402086470 hasConcept C54355233 @default.
• W2402086470 hasConcept C71924100 @default.
• W2402086470 hasConcept C86803240 @default.
• W2402086470 hasConceptScore W2402086470C126322002 @default.
• W2402086470 hasConceptScore W2402086470C141071460 @default.
• W2402086470 hasConceptScore W2402086470C142724271 @default.
• W2402086470 hasConceptScore W2402086470C2776870249 @default.
• W2402086470 hasConceptScore W2402086470C2776967927 @default.
• W2402086470 hasConceptScore W2402086470C2777975735 @default.
• W2402086470 hasConceptScore W2402086470C2781069245 @default.
• W2402086470 hasConceptScore W2402086470C523546767 @default.
• W2402086470 hasConceptScore W2402086470C54355233 @default.
• W2402086470 hasConceptScore W2402086470C71924100 @default.
• W2402086470 hasConceptScore W2402086470C86803240 @default.
• W2402086470 hasIssue "1" @default.
• W2402086470 hasLocation W24020864701 @default.
• W2402086470 hasOpenAccess W2402086470 @default.
• W2402086470 hasPrimaryLocation W24020864701 @default.
• W2402086470 hasRelatedWork W127138799 @default.
• W2402086470 hasRelatedWork W1585877160 @default.
• W2402086470 hasRelatedWork W1983087728 @default.
• W2402086470 hasRelatedWork W1993906621 @default.
• W2402086470 hasRelatedWork W2062035788 @default.
• W2402086470 hasRelatedWork W2062366715 @default.
• W2402086470 hasRelatedWork W2063986522 @default.
• W2402086470 hasRelatedWork W2083983048 @default.
• W2402086470 hasRelatedWork W2566616286 @default.
• W2402086470 hasRelatedWork W2793837683 @default.
• W2402086470 hasVolume "71" @default.
• W2402086470 isParatext "false" @default.
• W2402086470 isRetracted "false" @default.
• W2402086470 magId "2402086470" @default.
• W2402086470 workType "other" @default.